U.S. markets close in 28 minutes
  • S&P 500

    4,179.95
    -41.91 (-0.99%)
     
  • Dow 30

    33,385.54
    -437.91 (-1.29%)
     
  • Nasdaq

    14,052.04
    -109.31 (-0.77%)
     
  • Russell 2000

    2,234.84
    -52.62 (-2.30%)
     
  • Crude Oil

    71.71
    +0.67 (+0.94%)
     
  • Gold

    1,771.50
    -3.30 (-0.19%)
     
  • Silver

    25.95
    +0.09 (+0.36%)
     
  • EUR/USD

    1.1878
    -0.0033 (-0.27%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • GBP/USD

    1.3815
    -0.0109 (-0.79%)
     
  • USD/JPY

    110.1240
    -0.1070 (-0.10%)
     
  • BTC-USD

    35,542.78
    -2,233.13 (-5.91%)
     
  • CMC Crypto 200

    878.56
    -61.38 (-6.53%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

Opiant Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

SANTA MONICA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the first quarter ended March 31, 2021, after the financial markets close on Tuesday, May 11, 2021.

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Tuesday May 11, 2021. To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13718590. To access the live webcast, please go to the investors section of Opiant’s website at http://ir.opiant.com/. Following the live webcast, an archived version of the call will be available on the website.

Tuesday May 11 @ 4:30 pm ET

Domestic:

877-407-0792

International:

201-689-8263

Conference ID:

13718590

Webcast:

http://ir.opiant.com/

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com